BRIEF-Concert Pharmaceuticals Inc says topline results of phase 2 trial of CTP-656 are expected by year-end 2017

* Concert Pharmaceuticals Inc says topline results of phase

2 trial of CTP-656 are expected by year-end 2017

Read more